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Abstract
Background: Penicillium sp., other than P. marneffei, is an unusual cause of invasive disease. These
organisms are often identified in immunosuppressed patients, either due to human
immunodeficiency virus or from immunosuppressant medications post-transplantation. They are a
rarely identified cause of infection in immunocompetent hosts.
Case presentation: A 51 year old African-American female presented with an acute abdomen
and underwent an exploratory laparotomy which revealed an incarcerated peristomal hernia. Her
postoperative course was complicated by severe sepsis syndrome with respiratory failure,
hypotension, leukocytosis, and DIC. On postoperative day 9 she was found to have an anastamotic
breakdown. Pathology from the second surgery showed transmural ischemic necrosis with
angioinvasion of a fungal organism. Fungal blood cultures were positive for Penicillium chrysogenum
and the patient completed a 6 week course of amphotericin B lipid complex, followed by an
extended course oral intraconazole. She was discharged to a nursing home without evidence of
recurrent infection.
Discussion: Penicillium chrysogenum is a rare cause of infection in immunocompetent patients.
Diagnosis can be difficult, but Penicillium sp. grows rapidly on routine fungal cultures. Prognosis
remains very poor, but aggressive treatment is essential, including surgical debridement and the
removal of foci of infection along with the use of amphotericin B. The clinical utility of newer
antifungal agents remains to be determined.
Case report
A 51 year old African-American female, eight years status
post colostomy secondary to diverticulitis, presented to
the emergency department with a 48 hour complaint of
abdominal pain, nausea and vomiting. Vitals signs were
initially stable, physical exam was significant for dis-
tended, tender abdomen. A CT scan revealed extraluminal
intraperitoneal air and the patient was taken to the oper-
ating room. Exploratory laparotomy revealed an incarcer-
ated peristomal hernia with perforated small bowel.
Extensive enterolysis, small bowel resection and hernia
repair with permacol were performed. Cultures grew
Escherichia coli; pathology revealed only neutrophilic
inflammation. Due to the severity of disease, and disten-
tion of small bowel, the abdomen was left open to heal by
secondary intention. Her postoperative course was com-
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ure, hypotension, leukocytosis, and DIC. Broad spectrum
antibiotics were administered. The patient was also
treated with hydrocortisone 100 mg every 8 hours and
subsequently developed steroid induced hyperglycemia.
On postoperative day (POD) 3, a vacuum assisted closure
(VAC) device was placed to assist with fascial healing. The
sepsis syndrome resolved and the patient's condition
improved until POD 9, when stool was noticed collecting
within the VAC system. The patient was returned to the
operating room where she was found to have an anasta-
motic breakdown.
Pathology from the second surgery showed transmural
ischemic necrosis with angioinvasion of a fungal organ-
ism (see figure 1). Fungal blood cultures were obtained
and the patient was started on amphotericin B lipid com-
plex. Within 48 hours, fungal blood cultures were positive
for Penicillium sp. The patient completed a 6 week course
of amphotericin B lipid complex, followed by an extended
course oral intraconazole. The patient was eventually
transferred to a long-term rehabilitation facility, without
evidence of recurrent infection. The only identified risk
factors for invasive Penicillium infection were stress dose
steroids and broad spectrum antibiotics. Final fungal
identification demonstrated the organism to be Penicil-
lium chrysogenumA. In vitro susceptibility at 24 and 48 hrs
respectively was reported as: amphotericin B 0.5 µg/ml
and 1.0 µg/ml, itraconazole 0.06 µg/ml and 0.25 µg/ml,
and voriconazole 0.25 µg/ml and 1 µg/mlB.
Discussion
P. marneffei is a common cause of infection in the HIV
population in endemic areas of Southeast Asia. Infections
caused by other Penicillium species are rare [1]. A recent
review found only 34 cases. Sources of infection included
peritonitis in patients on peritoneal dialysis, endocarditis,
endophthalmitis, fungemia, esophagitis, and pulmonary
infection [2].
The genus Penicillium comprises approximately 225 spe-
cies, including P. chrysogenum (also called P. notatum), the
source of penicillin, and other species used in making
cheeses. They are a widespread group, found in soil,
decaying vegetation and in air. On microscopic examina-
tion Penicillium has hyaline and septated hyphae (in con-
Left panel: H&E stain of small bowel mucosa showing angioinvasionFigure 1
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appearance on culture media is pictured in the figure, with
characteristic green-blue color, velvety appearance, and
radial grooves at 25°C [4,5].
In general, Penicillium species have low pathogenicity and
infection is usually seen in immunocompromised indi-
viduals. Isolated cases have been reported without clear
immune suppression. The clinical presentation of disease
caused by Penicillium is diverse, and it is known to cause
pathology via direct infection, hypersensitivity reaction
[6], and pulmonary fibrosis [7]. In the case of infection,
the breadth of presentation is illustrated in the case review
by Lyratzopoulos et al. [2], which found cases of pulmo-
nary infection including lobar pneumonia, bronchiolitis
obliterans organizing pneumonia, localized granuloma,
fungus ball, and diffuse parenchymal infection. Cardiac
infection was primarily related to instrumentation or pro-
cedures (most commonly valve surgery with subsequent
endocarditis) [3,8]. Intra-abdominal infection was pre-
dominantly associated with peritoneal dialysis [9,10]. The
remaining infections included intracranial infection,
endophthalmitis, cutaneous infection, and infectious
esophagitis. This distribution of infection suggests that the
organism can disseminate through hematogenous as well
as direct mucosal invasion.
The primary difficulty in diagnosing infections by Penicil-
lium, due to its rarity, is a low clinical suspicion. It should
be considered in the situation of immune compromise or
after appropriate antibiotic course without resolution of
clinical symptoms. There are no clear indicators from his-
tory or physical exam that are specific for Penicillium infec-
tion, and it can cause a wide spectrum of disease.
Fortunately the organism often grows rapidly from nor-
mal fungal cultures [4], and thus it may be identified in
the course of a normal workup. Results from a biopsy, or
as in this case, surgical pathology, may be helpful when
available. However, one must also consider that positive
cultures from respiratory sources may not be associated
with invasive disease, but rather colonization [2]. Case
reports do not describe any specific imaging modalities
that aid in diagnosis [2], but imaging may play a role in
localization of foci of infection.
Multiple antifungal agents have been used with various
lengths of treatment for Penicillium infection. Amphoter-
icin B and itraconazole has been used with mixed results,
no doubt in part due to the variety of sites of infection,
and co-morbidity/underlying illnesses [2]. Combination
therapies with the aforementioned antifungal agents
(including ketoconazole) or flucytosine have also been
used with variable results. In vitro data suggests that newer
agents, such as Echinocandins (such as caspofungin or
micafungin), triazoles (such as voriconazole) and terbin-
afine have activity, though clinical data is still lacking
[11,12]. At this time the best evidence appears to support
amphotericin B in conjunction with strategies aimed at
removing the focus of infection, such as removal of lines,
replacement of infected valves, or surgical debridement of
affected tissue. There is no standard duration of therapy
(reports range from 2–12 weeks of treatment) [2] and
each case needs to be individualized to determine appro-
priate length of antifungal administration. Even with
these interventions, the prognosis for Penicillium infec-
tions remains poor.
This case highlights Penicillium as one of many causes of
infection in immunocompromised patients. Diagnosis
can be difficult, but Penicillium grows rapidly on routine
fungal cultures. Prognosis remains very poor, but aggres-
sive treatment is essential, including surgical debridement
and the removal of foci of infection along with the use of
amphotericin B. The clinical utility of newer antifungal
agents remains to be determined.
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